Q1FY18 : Unichem Lab's PAT tanks 95.2% sequentially
DSIJ Intelligence / 09 Aug 2017
The company's total sales for Q1FY18 came in at Rs 314.12 crore, which represents 8.66 per cent sequential decline and 8.14 per cent YoY decline. This was due to 9 per cent sequential decline in revenue from domestic operations.
Unichem Laboratories Ltd reported its results for the quarter ended June 30, 2017 today.
The company's total sales for Q1FY18 came in at Rs 314.12 crore, which represents 8.66 per cent sequential decline and 8.14 per cent YoY decline. This was due to 9 per cent sequential decline in revenue from domestic operations.
Its operating loss (EBIT) for the quarter amounted to Rs 10.59 crore and its EBIT margin stood at -3.37 per cent.
The company reported PAT of Rs 1.49 crore, which represents a sequential QoQ decline of 95.26 per cent and a YoY decline of 94.22 per cent.
Unichem Laboratories Ltd is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has various pharma products for addressing therapeutic areas as well as other formulation products.
The company's stock opened at Rs 260.35 on the BSE and currently quoting on Rs. 252 on closing basis after touching intra-day high of Rs. 260.35
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.